This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

Molecular Diagnostics Market & Forecast (By Application, Technology, Countries, Companies & Clinical Trials) To 2017: Global Analysis

Figure 5 1: Global – PCR Based Test Market (Million US$), 2010 – 2012Figure 5 2: Global – Forecast for PCR Based Test Market (Million US$), 2013 – 2017Figure 5 3: Global – PCR Related Technologies Market (Million US$), 2010 – 2012Figure 5 4: Global – Forecast for PCR Related Technologies Market (Million US$), 2013 – 2017Figure 5 5: Global – Non-PCR Test Market (Million US$), 2010 – 2012Figure 5 6: Global – Forecast for Non-PCR Test Market (Million US$), 2013 – 2017Figure 5 7: Global – Fish & Innovations Market (Million US$), 2010 – 2012Figure 5 8: Global – Forecast for Fish & Innovations Market (Million US$), 2013 – 2017Figure 5 9: Global – Biochips/ Microarrays Market (Million US$), 2010 – 2012Figure 5 10: Global – Forecast for Biochips/Micrroarrays Market (Million US$), 2013 – 2017Figure 5 11: Global – Biosensors Market (Million US$), 2010 – 2012Figure 5 12: Global – Forecast for Biosensors Market (Million US$), 2013 – 2017Figure 5 13: Global – Molecular Imaging Market (Million US$), 2010 – 2012Figure 5 14: Global – Forecast for Molecular Imaging Market (Million US$), 2013 – 2017Figure 5 15: Global – Other Technologies Market (Million US$), 2010 – 2012Figure 5 16: Global – Forecast for Other Technologies Market (Million US$), 2012 – 2017

Figure 6 1: US – Molecular Diagnostics Market (Million US$), 2002 – 2012Figure 6 2: US – Forecast for Molecular Diagnostics Market (Million US$), 2013 – 2017Figure 6 3: Europe – Molecular Diagnostics Market (Million US$), 2010 – 2012Figure 6 4: Europe – Forecast for Molecular Diagnostics Market (Million US$), 2013 – 2017Figure 6 5: China – Molecular Diagnostics Market (Million US$), 2010 – 2012Figure 6 6: China – Forecast for Molecular Diagnostics Market (Million US$), 2013 – 2017Figure 6 7: Japan – Molecular Diagnostics Market (Million US$), 2010 – 2012Figure 6 8: Japan – Forecast for Molecular Diagnostics Market (Million US$), 2013 – 2017Figure 6 9: India – Molecular Diagnostics Market (Million US$), 2010 – 2012Figure 6 10: India – Forecast for Molecular Diagnostics Market (Million US$), 2013 – 2017Figure 6 11: Brazil – Molecular Diagnostics Market (Million US$), 2007 – 2012Figure 6 12: Brazil – Forecast for Molecular Diagnostics Market (Million US$), 2013 – 2017Figure 6 13: Mexico – Molecular Diagnostics Market (Million US$), 2007 – 2012Figure 6 14: Mexico – Forecast for Molecular Diagnostics Market (Million US$), 2013 – 2017Figure 6 15: South Korea – Molecular Diagnostics Market (Million US$), 2005 – 2012Figure 6 16: South Korea – Forecast for Molecular Diagnostics Market (Million US$), 2013 – 2017Figure 6 17: Rest of World – Molecular Diagnostics Market (Million US$), 2010 – 2012Figure 6 18: Rest of World – Forecast for Molecular Diagnostics Market (Million US$), 2013 – 2017

Figure 7 1: Roche – Molecular Diagnostics Sales (Million US$), 2008 – 2012Figure 7 2: Roche – Forecast for Molecular Diagnostics Sales (Million US$), 2013 – 2017Figure 7 3: Abbott – Molecular Diagnostics Sales (Million US$), 2010 – 2012Figure 7 4: Abbott – Forecast for Molecular Diagnostics Sales (Million US$), 2013 – 2017Figure 7 5: Myriad Genetics – Molecular Diagnostics Sales (Million US$), 2007 – 2012Figure 7 6: Myriad Genetics – Forecast for Molecular Diagnostics Sales (Million US$), 2013 – 2017Figure 7 7: Qiagen – Molecular Diagnostics Sales (Million US$), 2009 – 2012Figure 7 8: Qiagen – Forecast for Molecular Diagnostics Sales (Million US$), 2013 – 2017Figure 7 9: BioMérieux – Molecular Diagnostics Sales (Million US$), 2010 – 2012Figure 7 10: BioMérieux – Forecast for Molecular Diagnostics Sales (Million US$), 2013 – 2017Figure 7 11: Other Companies – Molecular Diagnostics Sales (Million US$), 2010 – 2012Figure 7 12: Other Companies – Forecast for Molecular Diagnostics Sales (Million US$), 2013 – 2017

6 of 8

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
DOW 17,279.74 +13.75 0.08%
S&P 500 2,010.40 -0.96 -0.05%
NASDAQ 4,579.7890 -13.6380 -0.30%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs